Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017 Document date: 2017_11_7
ID: roslkxeq_292
Snippet: Disclosures: Disclosures to report. Dr Dunning has a consultancy role for AVACTA animal health. Dr Slater is Chief Scientific Officer for AVACTA animal health Dr's Moody and Barrass-Hemmens are assay development scientists employed by AVACTA animal health. Calcium oxalate (CaOx) ureterolithiasis has emerged as a cause of feline ureteral obstruction (UO) in the last few years. Several risk factors of UO were identified including hypercalcemia. One.....
Document: Disclosures: Disclosures to report. Dr Dunning has a consultancy role for AVACTA animal health. Dr Slater is Chief Scientific Officer for AVACTA animal health Dr's Moody and Barrass-Hemmens are assay development scientists employed by AVACTA animal health. Calcium oxalate (CaOx) ureterolithiasis has emerged as a cause of feline ureteral obstruction (UO) in the last few years. Several risk factors of UO were identified including hypercalcemia. One study showed that hypocalcemia is frequent in cats with urethral obstruction and hyperphosphatemia has been hypothesized as a causal factor. The aim of this retrospective study was to assess how ionized calcium concentration (iCa) varies in cats with UO after UO management.
Search related documents:
Co phrase search for related documents- animal health and AVACTA animal health: 1
- animal health and retrospective study: 1, 2, 3, 4
- animal health and retrospective study aim: 1
- animal health and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- calcium concentration and retrospective study: 1
Co phrase search for related documents, hyperlinks ordered by date